Hundreds of REI shoppers know that staying dry in rainy weather is easy when you have a good rain jacket, which is why they ...

Fintel reports that on November 6, 2025, JP Morgan maintained coverage of Teva Pharmaceutical Industries Limited - Depositary Receipt (NYSE:TEVA) with a Overweight recommendation. Analyst Price ...

Medincell is a clinical- and commercial-stage biopharmaceutical licensing company developing long-acting injectable treatments across multiple therapeutic areas. Our innovative treatments are designed ...

The big drugmaker unveiled its latest set of quarterly figures. Thanks to healthy rises in sales of key drugs, its revenue and profitability rose admirably. In its third quarter, Teva booked revenue ...

The big drugmaker unveiled its latest set of quarterly figures. In its third quarter, Teva booked revenue of $4.48 billion. That was 3% higher year over year, and much of that growth came from leading ...

The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a ...

Added 4,306,363 Teva shares, an estimated $75.64 million trade based on the average quarterly price for Q3 2025 Transaction represents a 0.68% increase in reportable U.S. equity assets under ...